These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8886295)
21. Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study. Rosen MI; Pearsall HR; McDougle CJ; Price LH; Woods SW; Kosten TR Am J Drug Alcohol Abuse; 1993; 19(4):451-64. PubMed ID: 8273766 [TBL] [Abstract][Full Text] [Related]
22. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study. Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358 [TBL] [Abstract][Full Text] [Related]
23. Detoxification with buprenorphine of a pregnant heroin addict. Annitto WJ Am J Addict; 2000; 9(1):92-3. PubMed ID: 10914298 [TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of thiamine on recognition memory and P300 in abstinent cocaine-dependent patients. Easton CJ; Bauer LO Psychiatry Res; 1997 May; 70(3):165-74. PubMed ID: 9211578 [TBL] [Abstract][Full Text] [Related]
25. Auditory target processing in methadone substituted opiate addicts: the effect of nicotine in controls. Müller BW; Specka M; Steinchen N; Zerbin D; Lodemann E; Finkbeiner T; Scherbaum N BMC Psychiatry; 2007 Nov; 7():63. PubMed ID: 17986348 [TBL] [Abstract][Full Text] [Related]
26. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients? Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244 [TBL] [Abstract][Full Text] [Related]
27. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification. Gariti P; Auriacombe M; Incmikoski R; McLellan AT; Patterson L; Dhopesh V; Mezochow J; Patterson M; O'Brien C J Subst Abuse; 1992; 4(3):299-308. PubMed ID: 1458046 [TBL] [Abstract][Full Text] [Related]
28. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial. Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987 [TBL] [Abstract][Full Text] [Related]
29. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation. Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. O'Connor PG; Oliveto AH; Shi JM; Triffleman EG; Carroll KM; Kosten TR; Rounsaville BJ; Pakes JA; Schottenfeld RS Am J Med; 1998 Aug; 105(2):100-5. PubMed ID: 9727815 [TBL] [Abstract][Full Text] [Related]
31. A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties. Bickel WK; Johnson RE; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR NIDA Res Monogr; 1987; 76():182-8. PubMed ID: 2449618 [No Abstract] [Full Text] [Related]
32. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. George TP; Chawarski MC; Pakes J; Carroll KM; Kosten TR; Schottenfeld RS Biol Psychiatry; 2000 Jun; 47(12):1080-6. PubMed ID: 10862808 [TBL] [Abstract][Full Text] [Related]
33. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Cheskin LJ; Fudala PJ; Johnson RE Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278 [TBL] [Abstract][Full Text] [Related]
34. Three methods of opioid detoxification in a primary care setting. A randomized trial. O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020 [TBL] [Abstract][Full Text] [Related]
35. Buprenorphine for the management of opioid withdrawal. Gowing L; Ali R; White J Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521 [TBL] [Abstract][Full Text] [Related]
36. Heroin anticraving medications: a systematic review. Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107 [TBL] [Abstract][Full Text] [Related]
37. Methods of detoxification and their role in treating patients with opioid dependence. O'Connor PG JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388 [No Abstract] [Full Text] [Related]
38. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [TBL] [Abstract][Full Text] [Related]
39. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication. Stefánsson SB; Jónsdóttir TJ Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851 [TBL] [Abstract][Full Text] [Related]
40. A comparative clinical study of the effect of WeiniCom, a Chinese herbal compound, on alleviation of withdrawal symptoms and craving for heroin in detoxification treatment. Hao W; Zhao M J Psychoactive Drugs; 2000; 32(3):277-84. PubMed ID: 11061678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]